Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9969 - 9976 of 12011 results

A Taste of Things to Come? Whole Foods Feels Sting of "Non-GMO" Litigation
November 13, 2014| Blog| Viewpoint

SEC's Increased Use of Administrative Proceedings Draws Criticism and Legal Challenges
November 12, 2014| Blog| Viewpoint

OCR's New Bulletin on Ensuring Privacy in Public Health Emergencies
November 12, 2014| Blog| Viewpoint

Hospital Alliance Deemed a Single Entity, Incapable of Conspiring
November 12, 2014| Blog| Viewpoint

Ohio District Court Deems Hospital Alliance a Single Entity Incapable of Conspiring Under the Antitrust Laws
November 12, 2014| Alert| Viewpoint

ML Strategies Energy and Environment Update: Week of 11/10/2014
November 11, 2014| Blog| Viewpoint

SEC Scrutiny of Crowdinvesting Sites Not Registered as Broker-Dealers
November 11, 2014| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|

Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|
